Author:
Kim Hyo Jeong,Han Ro,Kang Kyung Pyo,Ryu Jung-Hwa,Kim Myung-Gyu,Huh Kyu Ha,Park Jae Berm,Kim Chan-Duck,Han Seungyeup,Kim Hyung Woo,Kim Beom Seok,Yang Jaeseok
Abstract
AbstractIron plays an important role in hemodynamics and the immunity, independent of anemia. Since dynamic changes occur in iron storage after kidney transplantation (KT), we investigated the association between iron status and kidney outcomes in KT patients. We analyzed data from the KoreaN cohort study for Outcome in patients With KT (KNOW-KT). The iron status was classified into three groups based on ferritin or transferrin saturation (TSAT) levels one year after KT, with reference ranges of 20‒35% and 100‒300 ng/mL for TSAT and ferritin, respectively. The primary outcome was the composite outcome, which consisted of death, graft failure, and an estimated glomerular filtration rate decline ≥ 50%. In total, 895 patients were included in the final analysis. During a median follow-up of 5.8 years, the primary outcome occurred in 94 patients (19.8/1000 person-years). TSAT levels decreased one year after KT and thereafter gradually increased, whereas ferritin levels were maintained at decreased levels. The adjusted hazard ratios (95% confidence intervals) for the composite outcome were 1.67 (1.00–2.77) and 1.20 (0.60–2.40) in the TSAT > 35% and ferritin > 300 ng/mL groups, respectively. High iron status with high TSAT levels increases the risk of graft failure or kidney functional deterioration after KT.
Funder
The Research Program funded by the Korea Centers for Disease Control and Prevention
Publisher
Springer Science and Business Media LLC
Reference56 articles.
1. System, U. S. R. D. USRDS Annual Data Report: Epidemiology of Kidney Disease in the United States. (National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2020).
2. Tonelli, M. et al. Systematic review: Kidney transplantation compared with dialysis in clinically relevant outcomes. Am. J. Transplant. 11, 2093–2109. https://doi.org/10.1111/j.1600-6143.2011.03686.x (2011).
3. Sonoda, T. et al. Outcome of 3 years of immunosuppression with tacrolimus in more than 1000 renal transplant recipients in japan. Transplantation 75, 199–204. https://doi.org/10.1097/01.Tp.0000040867.67360.9f (2003).
4. Lamb, K. E., Lodhi, S. & Meier-Kriesche, H. U. Long-term renal allograft survival in the United States: A critical reappraisal. Am. J. Transplant. 11, 450–462. https://doi.org/10.1111/j.1600-6143.2010.03283.x (2011).
5. Meier-Kriesche, H. U., Schold, J. D., Srinivas, T. R. & Kaplan, B. Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am. J. Transplant. 4, 378–383. https://doi.org/10.1111/j.1600-6143.2004.00332.x (2004).
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献